← United States · Coverage record
US · SEC FORM 4
Fortrea Holdings Inc.
FTRE · Nasdaq · CIK 0001965040 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
26 Form 4 transaction lines observed in the same window
12 sales · 14 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-09-02 · Russell Erin L.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 12,564,688
- Previous report
- 12,550,566
- Avg daily volume
- 1,610,004
- Days to cover
- 7.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-09-02 | Russell Erin L | Purchase (P) | Common Stock | 9,854 | USD 10.15 | USD 100,018 | SEC filing ↗ |
| 2025-08-11 | NEUPERT PETER M | Purchase (P) | Common Stock | 32,500 | USD 6.26 | USD 203,450 | SEC filing ↗ |
| 2025-08-08 | NEUPERT PETER M | Purchase (P) | Common Stock | 30,000 | USD 6.79 | USD 203,700 | SEC filing ↗ |
| 2024-06-12 | Hanson James S. | Purchase (P) | Common Stock | 2,000 | USD 25.30 | USD 50,600 | SEC filing ↗ |
| 2024-05-29 | Pike Thomas | Purchase (P) | Common Stock | 10,000 | USD 24.81 | USD 248,100 | SEC filing ↗ |
| 2023-08-23 | Pike Thomas | Purchase (P) | Common Stock | 20,000 | USD 25.23 | USD 504,600 | SEC filing ↗ |
| 2023-08-23 | NEUPERT PETER M | Purchase (P) | Common Stock | 11,000 | USD 25.30 | USD 278,300 | SEC filing ↗ |
Form 4 evidence
46 transaction lines in the latest 365-day window; 166 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | Russell Carrie Elizabeth | Sale (S) | Common Stock | 246 | USD 16.85 | USD 4,145 | SEC filing ↗ |
| 2026-09-09 | Morais Mark A. | Sale (S) | Common Stock | 3,149 | USD 16.85 | USD 53,061 | SEC filing ↗ |
| 2026-09-08 | Russell Carrie Elizabeth | Option exercise / conversion (M) | Common Stock | 850 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | Russell Carrie Elizabeth | Sale (S) | Common Stock | 246 | USD 16.85 | USD 4,145 | SEC filing ↗ |
| 2026-09-09 | Morais Mark A. | Sale (S) | Common Stock | 3,149 | USD 16.85 | USD 53,061 | SEC filing ↗ |
| 2026-09-08 | Russell Carrie Elizabeth | Option exercise / conversion (M) | Common Stock | 850 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-08 | Morais Mark A. | Option exercise / conversion (M) | Common Stock | 7,157 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-19 | Morais Mark A. | Sale (S) | Common Stock | 4,892 | USD 18.19 | USD 88,985 | SEC filing ↗ |
| 2026-08-18 | Morais Mark A. | Option exercise / conversion (M) | Common Stock | 11,313 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-06 | Thakral Anshul | Sale (S) | Common Stock | 111,857 | USD 18.11 | USD 2,026,284 | SEC filing ↗ |
| 2026-08-05 | Thakral Anshul | Sale (S) | Common Stock | 99,869 | USD 19.16 | USD 1,913,111 | SEC filing ↗ |
| 2026-08-04 | Thakral Anshul | Option exercise / conversion (M) | Common Stock | 416,666 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-03 | SANDERS MACHELLE | Sale (S) | Common Stock | 9,700 | USD 18.01 | USD 174,697 | SEC filing ↗ |
| 2026-07-20 | Smith David Ross | Option exercise / conversion (M) | Common Stock | 6,598 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-10 | Smith David Ross | Option exercise / conversion (M) | Common Stock | 38,817 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-10 | Smith David Ross | Tax withholding (F) | Common Stock | 18,244 | USD 16.34 | USD 298,107 | SEC filing ↗ |
| 2026-06-10 | SANDERS MACHELLE | Option exercise / conversion (M) | Common Stock | 38,817 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-10 | Russell Erin L | Option exercise / conversion (M) | Common Stock | 38,817 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-10 | Ray Amrit | Option exercise / conversion (M) | Common Stock | 38,817 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-10 | Pesicka Edward A | Option exercise / conversion (M) | Common Stock | 38,817 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-10 | Morais Mark A. | Sale (S) | Common Stock | 4,674 | USD 16.82 | USD 78,617 | SEC filing ↗ |
| 2026-06-02 | Morais Mark A. | Sale (S) | Common Stock | 4,866 | USD 15.49 | USD 75,374 | SEC filing ↗ |
| 2026-06-02 | Mcconnell Jill G. | Sale (S) | Common Stock | 4,866 | USD 15.49 | USD 75,374 | SEC filing ↗ |
| 2026-06-01 | Morais Mark A. | Option exercise / conversion (M) | Common Stock | 11,006 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-01 | Mcconnell Jill G. | Option exercise / conversion (M) | Common Stock | 11,006 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-18 | Parks Robert | Sale (S) | Common Stock | 2,000 | USD 13.44 | USD 26,880 | SEC filing ↗ |
| 2026-05-14 | NEUPERT PETER M | Option exercise / conversion (M) | Common Stock | 148,536 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-20 | Russell Erin L | Option exercise / conversion (M) | Common Stock | 23,946 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-16 | Morais Mark A. | Sale (S) | Common Stock | 1,804 | USD 9.22 | USD 16,633 | SEC filing ↗ |
| 2026-03-16 | Mcconnell Jill G. | Sale (S) | Common Stock | 1,804 | USD 9.22 | USD 16,633 | SEC filing ↗ |
| 2026-03-13 | Morais Mark A. | Option exercise / conversion (M) | Common Stock | 4,284 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-13 | Mcconnell Jill G. | Option exercise / conversion (M) | Common Stock | 4,284 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Parks Robert | Sale (S) | Common Stock | 1,927 | USD 9.07 | USD 17,478 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | FTRE |
| CIK | 0001965040 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 166 transaction lines from 2023-06-20 to 2026-09-09 7 P purchase lines · 46 S sale lines · 113 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.